Mei Pharma Inc (MEIP)

Feb 03, 2025

MEI Pharma (NASDAQ:MEIP) Earns Buy Rating from Analysts at StockNews.com - Defense World

Feb 03, 2025

Feb 02, 2025

Scientist pleads guilty to stealing trade secrets for Chinese pharma company - Fox28 Savannah

Feb 02, 2025

Jan 31, 2025

Layoff Tracker: Rentschler’s Cell and Gene Therapy Exit Could Affect Up to 30 - BioSpace

Jan 31, 2025

Jan 27, 2025

ROSEN, A LEADING LAW FIRM, Encourages Infinity Pharmaceuticals, - GuruFocus.com

Jan 27, 2025

Jan 26, 2025

MEI Pharma (NASDAQ:MEIP) Now Covered by StockNews.com - Defense World

Jan 26, 2025

Jan 15, 2025

B-cell Non-hodgkin Lymphoma Clinical and Non-Clinical - openPR

Jan 15, 2025

Jan 10, 2025

MEI Pharma (NASDAQ:MEIP) Coverage Initiated by Analysts at StockNews.com - Defense World

Jan 10, 2025

Jan 08, 2025

Follicular Lymphoma Market Expected to rise, 2034 | Epizyme|Eisai, Bayer Healthcare Pharmaceuticals, Verastem Oncology, Gilead Sciences, TG Therapeutics, Bristol-Myers-Squibb, Roche, Incyte Corp - The Globe and Mail

Jan 08, 2025

Jan 08, 2025

A phase II study of zandelisib in patients with relapsed or refractory indolent non-Hodgkin lymphoma: ME-401-K02 study - Wiley Online Library

Jan 08, 2025

Dec 25, 2024

StockNews.com Initiates Coverage on MEI Pharma (NASDAQ:MEIP) - Defense World

Dec 25, 2024

Dec 24, 2024

Liquid Mushroom Market is Expected to Rise at CAGR of 6% to Reach US$ 15.74 Billion by 2034 | Fact.MR Report - GlobeNewswire Inc.

Dec 24, 2024

Dec 23, 2024

MEI Pharma stock hits 52-week low at $2.4 amid market challenges - Investing.com Canada

Dec 23, 2024

Dec 16, 2024

MEI Pharma stock hits 52-week low at $2.54 amid market challenges - Investing.com Australia

Dec 16, 2024

Dec 05, 2024

MEI Pharma (LTS:0JW9) 5-Day RSI : 36.09 (As of Dec. 05, 2024) - GuruFocus.com

Dec 05, 2024

Nov 30, 2024

MEIP (MEI Pharma) Financial Strength : 7 (As of Sep. 2024) - GuruFocus.com

Nov 30, 2024

Nov 29, 2024

Follicular Lymphoma Clinical Trial Pipeline Appears Robust With 50+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight - The Malaysian Reserve

Nov 29, 2024

Nov 27, 2024

MEI Pharma (LTS:0JW9) Total Inventories : $0.00 Mil (As of Sep. 2024) - GuruFocus.com

Nov 27, 2024

Nov 22, 2024

Deal Dispatch: Starbucks Explores China Sale, PE Firms Saddle Snack Company With DebtAmcor (NYSE:AMCR), Berry Global Gr (NYSE:BERY) - Benzinga

Nov 22, 2024

Nov 17, 2024

Deal Dispatch: Shell, Unilever And More Are On The Sell Side; The Onion Makes Alex Jones Cry Foul - Benzinga

Nov 17, 2024

Nov 13, 2024

MEI Pharma Reports Strategic Shift Amid Financial Losses - TipRanks

Nov 13, 2024

Nov 12, 2024

MEI Pharma, Inc. Reports Earnings Results for the First Quarter Ended September 30, 2024 - Marketscreener.com

Nov 12, 2024

Nov 12, 2024

MEI Pharma reports Q1 EPS ($1.20) vs. $8.46 last year - TipRanks

Nov 12, 2024

Nov 12, 2024

MEI Pharma Explores Strategic Sale Amid Cash Preservation Efforts, Reports $26.9M Cash Position | MEIP Stock News - StockTitan

Nov 12, 2024

Nov 08, 2024

Acute Myeloid Leukemia (AML) Treatment Market in APAC to Grow by USD 305.8 Million from 2024-2028, Driven by High Incidence and AI-Driven Market TransformationTechnavio - The Malaysian Reserve

Nov 08, 2024

Oct 28, 2024

Pre-market Movers: EVOK, HCTI, GLUE, MNPR... - RTTNews

Oct 28, 2024

Oct 28, 2024

Aardvark Therapeutics, Inc. agreed to acquire rights, title and interest in and to certain assets related to ME-344 from MEI Pharma, Inc. for $62.5 million. - Marketscreener.com

Oct 28, 2024

Oct 27, 2024

Data Readouts At EHA Congress 2021 (APTO, XFOR, GBT, CRIS…) - RTTNews

Oct 27, 2024

Oct 25, 2024

Stocks to Watch: MEI Pharma, Hawaiian Electric Industries - MarketWatch

Oct 25, 2024

Oct 25, 2024

MEI Shares Rise After Entering Asset Purchase Agreement Valued at Up to $62 Million - MarketWatch

Oct 25, 2024

Oct 25, 2024

MEI Pharma postpones special meeting to vote on Infinity deal until July 23 - MSN

Oct 25, 2024

Oct 24, 2024

MEIP (MEI Pharma) Free Cash Flow per Share : $-7.57 (TTM As of Jun. 2024) - GuruFocus.com

Oct 24, 2024

Oct 22, 2024

Post Polycythemia Vera Myelofibrosis Market: Holistic - openPR

Oct 22, 2024

Oct 14, 2024

Ampio Pharmaceuticals (NYSE:AMPE) Coverage Initiated by Analysts at StockNews.com - Defense World

Oct 14, 2024

Oct 09, 2024

MEI Pharma stock hits 52-week low at $2.72 amid market challenges - Investing.com India

Oct 09, 2024

Oct 08, 2024

MEI Pharma stock hits 52-week low at $2.72 amid market challenges By Investing.com - Investing.com South Africa

Oct 08, 2024

Oct 01, 2024

Acute Myeloid Leukemia Market Trends, Key Drivers, Opportunities, Leading Players And Forecast To 2033 - WhaTech

Oct 01, 2024

Sep 25, 2024

Histone Deacetylase 2 Industry Forecast (2024-2034) Under Inflation - Apiculture Market: Report ...

Sep 25, 2024

Sep 23, 2024

Myelodysplastic Syndrome Drugs Market Research Explores Size, Market Competitive Landscape, Business Growth... - WhaTech

Sep 23, 2024

Sep 22, 2024

Chronic Lymphocytic Leukemia Treatment Market Advancements Highlighted by Comprehensive Analysis, Advanceme... - WhaTech

Sep 22, 2024

Sep 20, 2024

Follicular Lymphoma Treatment Market Insights Discussed Regarding Size, Trends, and Overview Report 2024-2033 - WhaTech

Sep 20, 2024

Sep 20, 2024

MEI Pharma reviews strategic options amid fiscal changes - Investing.com India

Sep 20, 2024

Sep 19, 2024

MEI Pharma confirms continuation of evaluation of strategic alternatives - TipRanks

Sep 19, 2024

Sep 19, 2024

MEI Pharma Reports Fiscal Year End 2024 Cash Position - The Bakersfield Californian

Sep 19, 2024